Welcome

MORE SUPPORT IS A MOMENT AWAY

Please fill in the following fields to receive emails full of support, resources, and the latest information about DUPIXENT from DUPIXENT MyWay^®.

First Name

Last Name

Choose a Condition Moderate-to-Severe (Atopic Dermatitis or AD)
ECZEMA (Ages 6+ months) Add-on Maintenance Treatment for Uncontrolled Moderate-to-Severe Eosinophilic or Oral Steroid Dependent
ASTHMA (Ages 6+ years) Add-on Maintenance Treatment for Uncontrolled
CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (CRSwNP) (Ages 18+ years) EOSINOPHILIC ESOPHAGITIS (EoE) (Ages 1+
years weighing at least 33lb
(15 kg)) PRURIGO NODULARIS (PN) (Ages 18+ Years)

Zip Code

City

State

Address 1

Address 2 (optional)

By clicking 'Submit', I confirm that all information provided in this form is true, complete, and accurate.

DUPIXENT is a prescription medicine used:

to treat adults and children 6 months of age and older with moderate-to-severe eczema (atopic dermatitis or AD) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids. It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 6 months of age.
with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in adults and children 6 years of age and older whose asthma is not controlled with their current asthma medicines. DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. DUPIXENT may also help reduce the amount of oral corticosteroids you need while preventing severe asthma attacks and improving your breathing. DUPIXENT is not used to treat sudden breathing problems. It is not known if DUPIXENT is safe and effective in children with asthma under 6 years of age.
with other medicines for the maintenance treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled. It is not known if DUPIXENT is safe and effective in children with chronic rhinosinusitis with nasal polyposis under 18 years of age.
to treat adults and children 1 year of age and older with eosinophilic esophagitis (EoE), who weigh at least 33 pounds (15 kg). It is not known if DUPIXENT is safe and effective in children with eosinophilic esophagitis under 1 year of age, or who weigh less than 33 pounds (15 kg).
to treat adults with prurigo nodularis (PN). It is not known if DUPIXENT is safe and effective in children with prurigo nodularis under 18 years of age.

MORE SUPPORT IS A MOMENT AWAY

THANK YOU

DUPIXENT is a prescription medicine used: